Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The angioplasty balloons market has been steadily progressing due to increasing demand driven by cardiovascular health concerns and advancements in medical technology. This sector is poised for continued growth as clinical adoption rises and new innovations improve treatment outcomes. Below is a detailed examination of the market size, growth drivers, segmentation, trends, leading companies, and regional insights shaping the future of angioplasty balloons.

Steady Growth Outlook for the Angioplasty Balloons Market

The angioplasty balloons market has experienced consistent growth recently and is anticipated to expand from $2.85 billion in 2025 to $2.98 billion in 2026, at a compound annual growth rate (CAGR) of 4.6%. This upward trend during the historical period reflects factors such as the rising prevalence of coronary artery disease, wider clinical use of percutaneous transluminal angioplasty, increasing capacity of hospital catheterization labs, early availability of compliant and normal balloon catheters, and a growing incidence of peripheral artery disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15509&type=smp

Looking ahead, the market is forecasted to reach $3.47 billion by 2030, maintaining a CAGR of 3.9%. This growth is expected due to a surge in demand for drug-eluting and specialty balloons, expanding procedural volumes in peripheral angioplasty, and more treatments involving complex lesions requiring scoring and cutting balloons. The increasing use of minimally invasive cardiovascular therapies, coupled with greater investments in interventional cardiology infrastructure, also supports this positive trajectory. Key trends expected to drive market expansion include the broader acceptance of drug-eluting balloons for complex coronary and peripheral cases, the rising use of non-compliant and semi-compliant balloons to improve procedural accuracy, growing preference for scoring and cutting balloons in tough, calcified stenoses, and the ongoing shift towards balloon-based revascularization for patients unsuitable for stenting.

Rising Cardiovascular Disease Rates Boosting Angioplasty Balloon Demand

An important factor fueling growth in the angioplasty balloons market is the increasing prevalence of cardiovascular diseases worldwide. These conditions affect the heart and blood vessels, often leading to serious complications like heart attacks and strokes. The rise in cardiovascular disease is linked to sedentary lifestyles, poor dietary habits, increasing obesity rates, and aging populations—factors collectively contributing to higher patient numbers needing vascular intervention.

https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

#Angioplasty Balloons Market Largest Region: Which Geography Holds The Highest Market Share?

Angioplasty balloons play a crucial role in treating cardiovascular disease by widening narrowed or blocked blood vessels to restore blood flow and reduce the risk of adverse events. For example, data released in September 2024 by the Minnesota Department of Health showed that nearly 30% of adults in Minnesota had high blood pressure in 2023, equating to around 1.4 million people. Additionally, hypertensive diseases were linked to 14,225 deaths in 2022, accounting for almost 28% of all state fatalities. Such statistics highlight the growing demand for angioplasty balloons as part of cardiovascular disease management.

Segments Defining the Angioplasty Balloons Market Landscape

The angioplasty balloons market is segmented in multiple ways to capture its diverse product offerings and applications. By product type, the categories include Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, and Cutting Balloons. In terms of material, the market distinguishes between Non-Compliant and Semi-Compliant balloons. Application segments cover Coronary Angioplasty and Peripheral Angioplasty procedures. End users range from Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers to other healthcare facilities.

Further subsegments specify balloon types more precisely. Normal Balloons are divided into Non-Compliant and Compliant variants. Scoring Balloons split into Semi-Compliant Scoring and Non-Compliant Scoring types. Drug-Eluting Balloons are categorized based on the drug they release, such as Paclitaxel-Eluting, Sirolimus-Eluting, and Everolimus-Eluting Balloons. Cutting Balloons include versions equipped with cutting blades or radial scoring elements.

Innovations and Technological Advances Shaping Market Demand

Leading companies in the angioplasty balloons market are dedicating resources to developing cutting-edge products that enhance manufacturing precision and clinical performance. One notable advancement is the introduction of advanced medical balloon forming systems designed to produce high-pressure balloons with exact tolerances, critical for cardiac procedures.

For instance, in June 2024, Interface Catheter Solutions, a US-based catheter technology innovator, launched the BFM-5510 High Force Balloon Forming Machine. This benchtop system builds on the BFM-3310 platform and uses beryllium copper molds to precisely shape extruded balloon tubing. It is optimized for producing low- and non-compliant polymer balloons used in angioplasty, stenting, and other vital cardiac treatments. The technology enables manufacturers to meet the increasing demand for larger, thicker, and more complex medical balloons with enhanced quality controls.

Prominent Market Players Driving Competition and Innovation

The angioplasty balloons market features several key players who lead advancements and supply in this space. These include Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Translumina GmbH, and Concept Medical Inc. Their competitive strategies focus on product innovation, expanding clinical applications, and improving patient outcomes.

Geographical Markets with Strong Presence and Growth Potential

In 2025, North America held the largest share of the angioplasty balloons market, reflecting well-established healthcare infrastructure and high clinical adoption rates. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth in the coming years, driven by increasing healthcare investments, rising cardiovascular disease incidence, and expanding access to minimally invasive therapies.

The angioplasty balloons market report covers various regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model